NCT00580229View on ClinicalTrials.gov

A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2011

Conditions
Rheumatoid Arthritis
Interventions
DRUG

prednisone

prednisone 40mg by mouth 30-60 minutes prior to rituximab

Trial Locations (2)

33612

University of South Florida, Tampa

34684

Arthritis Research of Florida, Inc., Palm Harbor

All Listed Sponsors
lead

University of South Florida

OTHER

NCT00580229 - A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis. | Biotech Hunter | Biotech Hunter